| 000 | 01549 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513134357.0 | ||
| 264 | 0 | _c19980212 | |
| 008 | 199802s 0 0 eng d | ||
| 022 | _a0098-7484 | ||
| 024 | 7 |
_a10.1001/jama.279.5.384 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHolmberg, S D | |
| 245 | 0 | 0 |
_aPossible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) Investigators. _h[electronic resource] |
| 260 |
_bJAMA _cFeb 1998 |
||
| 300 |
_a384-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xprevention & control |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibiotics, Antitubercular _xtherapeutic use |
| 650 | 0 | 4 |
_aAzithromycin _xtherapeutic use |
| 650 | 0 | 4 |
_aClarithromycin _xtherapeutic use |
| 650 | 0 | 4 |
_aCryptosporidiosis _xprevention & control |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLikelihood Functions |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRifabutin _xtherapeutic use |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 700 | 1 | _aMoorman, A C | |
| 700 | 1 | _aVon Bargen, J C | |
| 700 | 1 | _aPalella, F J | |
| 700 | 1 | _aLoveless, M O | |
| 700 | 1 | _aWard, D J | |
| 700 | 1 | _aNavin, T R | |
| 773 | 0 |
_tJAMA _gvol. 279 _gno. 5 _gp. 384-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.279.5.384 _zAvailable from publisher's website |
| 999 |
_c9428563 _d9428563 |
||